Gregory C Bloom

Title: Gregory C Bloom: Innovator in Cancer Prognosis and Classification

Introduction

Gregory C Bloom is a notable inventor based in Tampa, FL, who has made significant contributions to the field of cancer research. With a total of 3 patents, his work focuses on improving cancer prognosis and classification systems, which are crucial for effective treatment and patient care.

Latest Patents

One of his latest patents is titled "Methods and systems for predicting cancer outcome." This invention provides a molecular marker set that can be used for the prognosis of colorectal cancer in patients. It also includes methods and computer systems for evaluating prognosis based on this molecular marker set, determining chemotherapy options, and enrolling patients in clinical trials. Another significant patent is the "Hybrid model for the classification of carcinoma subtypes." This two-tiered classification system integrates with existing algorithms used by pathologists to identify the site of origin for malignancies with unknown primary sources. It combines morphology, immunohistochemical studies, and microarray-based gene expression classifiers to assist pathologists in refining their decision-making processes.

Career Highlights

Gregory has worked with esteemed institutions such as the H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida. His experience in these organizations has allowed him to contribute to groundbreaking research and innovations in cancer treatment.

Collaborations

Throughout his career, Gregory has collaborated with notable professionals in the field, including Timothy J Yeatman and Steven A Eschrich. These collaborations have further enhanced the impact of his work in cancer research.

Conclusion

Gregory C Bloom's innovative patents and career achievements highlight his dedication to advancing cancer prognosis and classification. His contributions are vital for improving patient outcomes and enhancing the effectiveness of cancer treatments.